Literature DB >> 24565736

ACIDFORM: a review of the evidence.

Lisa L Bayer1, Jeffrey T Jensen2.   

Abstract

OBJECTIVE: ACIDFORM is a candidate microbicide with spermicidal properties. A large Phase 3 trial is underway, and it is anticipated that this product will be approved for contraceptive use and marketed soon in the United States. The goal of this article is to critically review the evidence supporting the properties, safety profile and different uses of ACIDFORM gel. STUDY
DESIGN: We searched PubMed and Medline for any published literature on ACIDFORM.
RESULTS: ACIDFORM is an acidifying agent that works by lowering the vaginal pH to enhance the normal vaginal defenses. In addition to strong acid-buffering properties, ACIDFORM has high bioadhesive and viscosity-retaining properties. Several Phase 1 clinical trials have demonstrated the vaginal safety of ACIDFORM used alone or in combination with a diaphragm, although dose-dependent side effects appear to be present. Studies investigating the efficacy of ACIDFORM against sexually transmitted infections (STIs) are promising, but further trials are needed.
CONCLUSIONS: The properties of ACIDFORM offer many advantages for use, either alone or in combination with another active ingredient, such as Tenofovir. Potential applications for ACIDFORM include use as a personal lubricant, a vaginal contraceptive (alone or with a barrier method) and a microbicidal product or as a formulation vehicle for an active ingredient. IMPLICATIONS: ACIDFORM is a candidate female-controlled vaginal preparation with microbicidal and spermicidal properties. A dual protection method could prevent unwanted pregnancies and reduce the risk of STI acquisition.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acid-buffering; Acidifying agent; Microbicide; Spermicide

Mesh:

Substances:

Year:  2014        PMID: 24565736     DOI: 10.1016/j.contraception.2014.01.015

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  5 in total

Review 1.  Biomaterials and Contraception: Promises and Pitfalls.

Authors:  Isabella Claure; Deborah Anderson; Catherine M Klapperich; Wendy Kuohung; Joyce Y Wong
Journal:  Ann Biomed Eng       Date:  2019-11-07       Impact factor: 3.934

Review 2.  Mechanisms of action of currently available woman-controlled, vaginally administered, non-hormonal contraceptive products.

Authors:  B Todd Chappell; Brooke L Griffin; Brandon Howard
Journal:  Ther Adv Reprod Health       Date:  2022-07-07

3.  A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial.

Authors:  Michael A Thomas; B Todd Chappell; Bassem Maximos; Kelly R Culwell; Clint Dart; Brandon Howard
Journal:  Contracept X       Date:  2020-07-01

4.  New Contraception Update - Annovera, Phexxi, Slynd, and Twirla.

Authors:  Courtney C Baker; Melissa J Chen
Journal:  Curr Obstet Gynecol Rep       Date:  2022-01-06

5.  Multifunctional Tannic Acid/Silver Nanoparticle-Based Mucoadhesive Hydrogel for Improved Local Treatment of HSV Infection: In Vitro and In Vivo Studies.

Authors:  Emilia Szymańska; Piotr Orłowski; Katarzyna Winnicka; Emilia Tomaszewska; Piotr Bąska; Grzegorz Celichowski; Jarosław Grobelny; Anna Basa; Małgorzata Krzyżowska
Journal:  Int J Mol Sci       Date:  2018-01-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.